GE HealthCare has unveiled its first combined software release with MIM Encore™, a comprehensive digital imaging platform designed to enhance diagnostic capabilities across oncology, cardiology, and neurology departments. The integrated solution represents a significant advancement in precision care technology, combining proprietary GE HealthCare features with MIM Software’s established imaging algorithms.
GE HealthCare has positioned itself at the forefront of precision cardiac diagnostics with the commercial launch of Flyrcado™ (flurpiridaz F 18) injection, marking the first new PET myocardial perfusion tracer to enter clinical practice in nearly two decades. The advanced molecular imaging agent represents a significant technological leap in coronary artery disease detection, offering clinicians […]
Sky Labs, a South Korean digital healthcare startup, has gained significant international recognition for its pioneering ring-type cuffless blood pressure monitoring technology following presentations at the European Society of Hypertension (ESH) 2025 conference in Milan, Italy.
Oxford-based Genomics has announced the nationwide launch of its Health Insights predictive clinical tool across Great Britain, marking the first UKCA-marked and MHRA registered test that combines genetic and clinical factors to predict and prevent common diseases. The announcement was made at HLTH Europe 2025 in Amsterdam on 17 June 2025.
Royal Philips has announced the global launch of its Flash Ultrasound System 5100 POC, a next-generation point-of-care (POC) ultrasound system designed for critical care environments. The system targets anaesthesia, critical care, emergency medicine, and musculoskeletal imaging applications, combining exceptional image clarity with smart automation in a highly portable platform.
Bayer has submitted a groundbreaking marketing authorisation application to Japan’s Ministry of Health, Labour, and Welfare for gadoquatrane, an investigational contrast agent that could significantly improve MRI safety protocols. The macrocyclic agent delivers a remarkable 60% reduction in gadolinium exposure compared to standard-of-care agents, addressing critical concerns about cumulative gadolinium retention in patients requiring multiple […]
Roche has announced the CE marking of its innovative Chest Pain Triage algorithm, designed to enhance the detection of Acute Coronary Syndrome (ACS) in emergency departments. Developed in collaboration with Universitätsklinikum Heidelberg, this IVD medical device aims to transform cardiac care by providing standardised assessment tools for clinicians managing chest pain presentations.
Diagnostics.ai has launched what it claims is the industry’s first fully transparent machine learning platform for clinical real-time PCR diagnostics, achieving CE-IVDR certification as new European regulatory deadlines take effect. The PCR.AI platform represents a significant advancement in diagnostic AI transparency, demonstrating exactly how each result is achieved – a first for molecular testing machine […]
Royal Philips has introduced its VeriSight Pro 3D Intracardiac Echocardiography (ICE) catheter across European markets, bringing advanced real-time cardiac visualisation directly into the heart chambers. The innovative imaging system promises to transform structural heart interventions by eliminating the need for general anaesthesia whilst delivering high-resolution 2D and 3D cardiac anatomy visualisation.
Royal Philips has launched SmartSpeed Precise, a breakthrough dual-AI engine technology that accelerates MRI scanning whilst delivering enhanced image quality for improved diagnostic confidence. The next-generation solution, which builds upon Philips’ award-winning Compressed SENSE and SmartSpeed technologies.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
